- Corporate Officers - E
- Eastham Karin
Insider Trading History of Eastham Karin
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Eastham Karin since 2015.
This trader's CIK number is 1231845.
At the time of last reporting, Eastham Karin was the Director of Veracyte, Inc.. (stock ticker symbol VCYT).
Also see all insider trading activities at Veracyte, Inc..
Note that in the past
EASTHAM KARIN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Illumina, Inc. (ILMN) by Eastham Karin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ILMN | 0 | $0 | 5,000 | $1,470,170 | 4,000 | $284,360 |
| 2018 | ILMN | 0 | $0 | 3,000 | $727,117 | 2,000 | $142,180 |
| 2017 | ILMN | 0 | $0 | 10,800 | $2,106,000 | 10,800 | $817,128 |
| 2016 | ILMN | 0 | $0 | 5,000 | $725,044 | 5,000 | $181,450 |
| 2015 | ILMN | 0 | $0 | 29,300 | $5,669,863 | 29,300 | $1,186,643 |
Yearly summary of insider trading at Geron Corp (GERN) by Eastham Karin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | GERN | 0 | $0 | 0 | $0 | 35,000 | $38,500 |
| 2022 | GERN | 0 | $0 | 0 | $0 | 35,000 | $49,350 |
Yearly summary of insider trading at Veracyte, Inc. (VCYT) by Eastham Karin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | VCYT | 0 | $0 | 4,590 | $122,387 | 0 | $0 |
| 2024 | VCYT | 0 | $0 | 24,731 | $796,226 | 2,500 | $26,025 |
| 2023 | VCYT | 0 | $0 | 10,000 | $250,000 | 10,000 | $121,199 |
| 2021 | VCYT | 0 | $0 | 18,227 | $72,667,077 | 5,000 | $60,599 |
Yearly summary of insider trading at Nektar Therapeutics (NKTR) by Eastham Karin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | NKTR | 0 | $0 | 21,267 | $76,773 | 0 | $0 |
Insider trading activities at 4 companies by Eastham Karin:
1. Illumina, Inc. (ILMN)
2. Geron Corp (GERN)
3. Veracyte, Inc. (VCYT)
4. Nektar Therapeutics (NKTR)
Table 1. Insider trading of Illumina, Inc. (ILMN) by Eastham Karin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-01-02 | ILMN | Option Ex | 4,000 | 71.09 | 284,360 |
| 2019-01-02 | ILMN | Sale | 5,000 | 294.03 | 1,470,170 |
| 2018-05-21 | ILMN | Sale | 1,000 | 269.50 | 269,503 |
| 2018-03-05 | ILMN | Option Ex | 2,000 | 71.09 | 142,180 |
| 2018-03-05 | ILMN | Sale | 2,000 | 228.81 | 457,614 |
| 2017-08-02 | ILMN | Sale | 10,800 | 195.00 | 2,106,000 |
| 2017-08-02 | ILMN | Option Ex | 10,800 | 75.66 | 817,128 |
| 2016-06-01 | ILMN | Option Ex | 5,000 | 36.29 | 181,450 |
| 2016-06-01 | ILMN | Sale | 5,000 | 145.01 | 725,044 |
| 2015-09-08 | ILMN | Sale | 4,300 | 195.76 | 841,768 |
| 2015-09-08 | ILMN | Option Ex | 4,300 | 44.51 | 191,393 |
| 2015-06-01 | ILMN | Sale | 5,000 | 205.88 | 1,029,405 |
| 2015-06-01 | ILMN | Option Ex | 5,000 | 39.14 | 195,700 |
| 2015-02-02 | ILMN | Sale | 10,000 | 193.23 | 1,932,280 |
| 2015-02-02 | ILMN | Option Ex | 10,000 | 43.66 | 436,650 |
| 2015-01-02 | ILMN | Option Ex | 10,000 | 36.29 | 362,900 |
| 2015-01-02 | ILMN | Sale | 10,000 | 186.64 | 1,866,410 |
Table 2. Insider trading of Geron Corp (GERN) by Eastham Karin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-01-13 | GERN | Option Ex | 35,000 | 1.10 | 38,500 |
| 2022-04-20 | GERN | Option Ex | 35,000 | 1.41 | 49,350 |
Table 3. Insider trading of Veracyte, Inc. (VCYT) by Eastham Karin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-13 | VCYT | Sale | 4,590 | 26.66 | 122,387 |
| 2024-11-19 | VCYT | Sale | 14,731 | 37.76 | 556,301 |
| 2024-07-16 | VCYT | Sale | 7,500 | 25.00 | 187,500 |
| 2024-06-07 | VCYT | Option Ex | 2,500 | 10.41 | 26,025 |
| 2024-06-07 | VCYT | Sale | 2,500 | 20.97 | 52,425 |
| 2023-02-28 | VCYT | Option Ex | 10,000 | 12.12 | 121,199 |
| 2023-02-28 | VCYT | Sale | 10,000 | 25.00 | 250,000 |
| 2021-12-17 | VCYT | Option Ex | 5,000 | 12.12 | 60,599 |
| 2021-12-17 | VCYT | Sale | 5,000 | 45.00 | 225,000 |
| 2021-11-01 | VCYT | Sale | 4,400 | 16,370.74 | 72,031,238 |
| 2021-08-02 | VCYT | Sale | 4,400 | 44.06 | 193,859 |
| 2021-05-03 | VCYT | Sale | 4,427 | 49.01 | 216,980 |
Table 4. Insider trading of Nektar Therapeutics (NKTR) by Eastham Karin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-13 | NKTR | Sale | 21,267 | 3.61 | 76,773 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Eastham Karin
(Director of Veracyte, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.